Overview


According to FutureWise analysis the market for Preterm Birth Prevention and Management in 2023 is US$ 1.56 billion, and is expected to reach US$ 3.41 billion by 2031 at a CAGR of 10.30%.

The rising necessity of preventing preterm births and increased emphasis on targeted therapies and care standards are some of the key factors contributing to the market growth. According to the data provided by the WHO, every year, over 15 million births are preterm. Complications arising from preterm births is the primary cause of mortality in children under the age of 5 with over 1 million deaths recorded in 2015. Over 70% of these deaths are preventable with cost-effective interventions. Due to these factors, it is estimated that the market shall propel during the forecast period.

Treating progesterone during the pregnancy process shall help many women to be prevented from premature birth and a 17P shot is very effective in such cases. Vaginal progesterone and progesterone shots are two types of progesterone treatments. Vaginal progesterone helps in reducing premature birth in case the women is carrying one baby and has a shorter cervix. The progesterone shots help in reducing the risk of premature birth if the women previously had a premature birth. Such factors shall boost the preterm birth prevention and management market growth.

  • AbbVie Inc.
  • Allergan
  • AMAG Pharmaceuticals
  • Bayer AG
  • Ferring B.V.
  • Merck & Co. Inc.
  • Mylan N.V.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Therapy Type

  • Progesterone Therapy
  • Corticosteroid Therapy
  • Tocolytics Therapy
  • Antibiotics Therapy
  • Heparin Profylaxis Therapy
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Vaginal

By Distribution Channel

  • Drug Stores
  • Hospital Pharmacies
  • Mail Order Pharmacies
  • E-Pharmacies
  • Retail Pharmacies
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

The market is fragmented into therapy type, route of administration, distribution channel and region. The therapy type segment is categorised into progesterone therapy, tocolytics therapy, corticosteroid therapy, antibiotics therapy, heparin profylaxis therapy and others. The route of administration segment is diversified into oral, vaginal and parenteral. The oral route is predicted to hold the largest preterm birth prevention and management market share during the forecast period. The distribution channel segment is bifurcated into hospital pharmacies, online pharmacies, drug stores.

The North America region is predicted to lead the market during the forecast period owing to increased birth rates, rising awareness amongst women regarding preterm birth and major market players have their headquarters in the region. As per the Centers for Disease Control and Prevention, over 1 in every 10 infants were born premature in the US in the year 2018. Such statistics shall provide a boost to the market growth in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Preterm Birth Prevention and Management Market By Therapy Type, By Route Of Administration, By Distribution Channel And By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Preterm Birth Prevention and Management Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework on Country Level
         6.1 . Reimbursement Framework
         6.2 . Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1 . Market Driver Analysis
         1.2 . Market Restraint Analysis
         1.3 . Industry Challenges
  • 6.  Preterm Birth Prevention and Management Market Analysis tools

    •   1. Industry Analysis - Porter’s
         1.1 . Supplier Power
         1.2 . Buyer Power
         1.3 . Substitution Threat
         1.4 . Threat from new entrants
         1.5 . Competitive Rivalry
        2. Pestel Analysis
         2.1 . Political Landscape
         2.2 . Environmental Landscape
         2.3 . Social landscape
         2.4 . Technology landscape
         2.5 . Legal Landscape

  • 7.   Preterm Birth Prevention and Management Market, By Therapy Type Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Progesterone Therapy
        2. Corticosteroid Therapy
        3. Tocolytics Therapy
        4. Antibiotics Therapy
        5. Heparin Profylaxis Therapy
        6. Others

  • 8.   Preterm Birth Prevention and Management Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Oral
        2. Parenteral
        3. Vaginal

  • 9.   Preterm Birth Prevention and Management Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD million)

    •   1. Drug Stores
        2. Hospital Pharmacies
        3. Mail Order Pharmacies
        4. E-Pharmacies
        5. Retail Pharmacies
        6. Others

  • 10.  North America Preterm Birth Prevention and Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.
         2.2. Canada
         2.3. Mexico
         2.4. Rest of North America
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.  Latin America Preterm Birth Prevention and Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (US$ Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (US$ Million) Forecast for Latin America 2023-2031

  • 12.  Europe Preterm Birth Prevention and Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (US$ Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Switzerland
         2.6. Spain
         2.7. Russia
         2.8. Poland
         2.9. Rest of Western Europe
        3. Market Size (US$ Million) Forecast for Europe 2023-2031

  • 13.  Asia Pacific Preterm Birth Prevention and Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. Korea
         2.5. India
         2.6. Australia and New Zealand
         2.7. ASEAN
         2.8. Rest of Asia Pacific
        3. Market Size (US$ Million) Forecast for Asia Pacific 2023-2031

  • 14.  Middle East and Africa Preterm Birth Prevention and Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1 . GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (US$ Million) Forecast for MEA 2023-2031

  • 15.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)

    •   1. AbbVie Inc.
         1.1. Company Overview (HQ, Business Segments, Employee Strength)
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Allergan
         2.1. Company Overview (HQ, Business Segments, Employee Strength)
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. AMAG Pharmaceuticals
         3.1. Company Overview (HQ, Business Segments, Employee Strength)
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bayer AG
         4.1. Company Overview (HQ, Business Segments, Employee Strength)
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Ferring B.V.
         5.1. Company Overview (HQ, Business Segments, Employee Strength)
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Merck & Co. Inc.
         6.1. Company Overview (HQ, Business Segments, Employee Strength)
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Pfizer Inc.
         7.1. Company Overview (HQ, Business Segments, Employee Strength)
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Mylan N.V.
         8.1. Company Overview (HQ, Business Segments, Employee Strength)
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Teva Pharmaceutical Industries Ltd.
         9.1. Company Overview (HQ, Business Segments, Employee Strength)
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   Competitive Intelligence and Competitive Matrix

    •   1. Competitive Intelligence
        2. Competitive Matrix

  • 19.   Major Deals and Strategic Alliances Analysis

    •   1. Joint ventures
        2. Mergers and acquisitions
        3. Licensing and partnerships
        4. Technology Collaborations
        5. Strategic Divestments
        6. Market Entry Strategies

  • 20.   Relevant Case Studies and Latest News Updates
  • 21.  FutureWise SME Key Takeaway Points for Client

    •   


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11